News

The collaboration further expands Qiagen’s testing portfolio for the early detection of diseases and individualised treatment of patients thereby strengthening Qiagen’s molecular diagnostics offering for applications in prevention

Titan Pharmaceuticals is the assignee of this patent which claims a method for treating opiate addiction with a subcutaneously implanted device comprising buprenorphine and ethylene vinyl acetate, a

Fibrocaps is based on a mixture of two essential blood clotting proteins, fibrinogen and thrombin, and is a dry powder topical tissue sealant in development to stop bleeding

The BD Bactec MGIT 320 system is half the physical size of the BD Bactec MGIT 960 system, a fully automated system for mycobacterial liquid culture and susceptibility

Biotivia claimed that Florativia is the world’s first supplement combining both prebiotics and probiotics in one Twist ‘n Shake bottle. According to Florativia its new packaging technology separates

Mr Madsen joined Novavax in 2008 as director of BioProcess Development with responsibility for development of Novavax’s seasonal and pandemic influenza vaccines for clinical testing. Earlier, he was

The trial was conducted by Roche and Genentech, Curis’ collaborator and a wholly owned member of the Roche Group. GDC-0449 is being developed by Roche and Genentech under

Evotec had entered into a multi-year, multi-target drug discovery alliance with Boehringer Ingelheim in 2004, to jointly identify and develop preclinical development candidates for the treatment of various

The committee’s vote followed a review of data from the Ulipristal Acetate preclinical and clinical development program, involving more than 4000 women from the US and Europe. The